Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
PrECOG, LLC.
Fundación GECP
Instituto Nacional de Cancerologia de Mexico
IRCCS San Raffaele
Ziauddin University
Qianfoshan Hospital
Peking University Cancer Hospital & Institute
Azienda Policlinico Umberto I
Aetion, Inc.
Aetion, Inc.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Swami Rama Himalayan University
University Medical Center Groningen
Vall d'Hebron Institute of Oncology
Seoul National University Hospital
Moscow Clinical Scientific Center
Fox Chase Cancer Center
European Lung Cancer Working Party
Sungkyunkwan University
Xijing Hospital
Konkuk University Medical Center
Wake Forest University Health Sciences
University of California, San Francisco
Rennes University Hospital